Skip to content
Screener

Nuvectis Pharma, Inc. NVCT Q2 2025 earnings

Reported August 5, 2025 · Before market open

EPS-$0.30Miss by $0.05
EPS estimate-$0.25

Next report

Nov 3, 2026 (in 2 months)
EPS estimate-$0.22

Financials

Q2 2025

Income statement

See full
Operating income-$6.6M-42.0%
Net income-$6.3M-43.0%
EPS (diluted)-$0.30-15.4%

Balance sheet

See full
Cash & equivalents$26.8M+47.9%
Total equity$16.9M+34.7%
Total assets$27.0M+47.6%

Cash flow

See full
Operating cash flow-$3.4M-11.5%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$166.73M+59.1%

Returns & leverage

See full
Return on equity-150.1%+30.5pp
Current ratio2.7×-0.5×

FAQ

When did Nuvectis Pharma, Inc. report Q2 2025 earnings?
Nuvectis Pharma, Inc. (NVCT) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Nuvectis Pharma, Inc.'s Q2 2025 revenue and EPS?
Nuvectis Pharma, Inc. reported eps of $-0.30 for Q2 2025.
Did Nuvectis Pharma, Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.25 by $0.05.
How did Nuvectis Pharma, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 15.4% from $-0.26.
Where can I find Nuvectis Pharma, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-073967) and the 10-Q periodic report (0001558370-25-010203) directly on SEC EDGAR. The filing index links above go to sec.gov.